...
首页> 外文期刊>Infectious Diseases and Therapy >Prognostic Role of Soluble Urokinase Plasminogen Activator Receptor at the Emergency Department: A Position Paper by the Hellenic Sepsis Study Group
【24h】

Prognostic Role of Soluble Urokinase Plasminogen Activator Receptor at the Emergency Department: A Position Paper by the Hellenic Sepsis Study Group

机译:可溶性尿激酶纤溶酶原激活因子在急诊部的预后作用:Hellenic Sepsis研究组的位置纸

获取原文
   

获取外文期刊封面封底 >>

       

摘要

In light of the accumulating evidence on the negative predictive value of soluble urokinase plasminogen activator receptor (suPAR), a group of experts from the fields of intensive care medicine, emergency medicine, internal medicine and infectious diseases frame a position statement on the role of suPAR in the screening of patients admitted to the emergency department. The statement is framed taking into consideration existing publications and our own research experience. The main content of this statement is that sUPAR is a non-specific marker associated with a high negative predictive value for unfavourable outcomes; levels 6?ng/ml are an alarming sign of risk for unfavourable outcomes. However, the suPAR levels should always be interpreted in light of the patient's history.
机译:鉴于可溶性尿激酶纤溶酶原激活剂受体(SUPAR)负面预测值的累积证据,一组来自密集护理医学,急诊医学,内科和传染病的领域的专家框架对SUPAR作用的立场陈述在筛查患者入院急诊部门的患者。该声明被框架考虑到现有出版物和我们自己的研究经验。本声明的主要内容是,Supar是与不利结果的高负预测值相关的非特定标记; 6级?Ng / ml是不利结果的令人担忧的迹象。但是,根据患者的历史,应始终解释Supar级别。

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号